AHFS September 2025 Update

This update contains 4 new monographs and 37 revised monographs.

New monographs: BCG (Intravesical); Garadacimab-gxii; Sebetralstat; Taletrectinib Adipate.

Revised monographs: Acalabrutinib; Agalsidase Beta; Amivantamab-vmjw; Amlodipine; Artesunate; Axicabtagene Ciloleucel; Aztreonam and Avibactam Sodium; BCG Vaccine; Bevacizumab; Brexucabtagene Autoleucel; Chenodio; Ciltacabtagene Autoleucel; COVID-19 Vaccine, Adjuvanted (Novavax)(2024-2025 Formula); Datopotamab deruxtecan-dlnk; Diclofenac; Flurbiprofen Sodium (Systemic); Haloperidol; Idecabtagene Vicleucel; Imetelstat Sodium; Lisdexamfetamine Dimesylate; Lisocabtagene Maraleucel; Maralixibat Chloride; Methamphetamine Hydrochloride; Mirdametinib; Natalizumab; Nogapendekin alfa inbakicept-pmln; OLANZapine; Pegfilgrastim; Phenylephrine Hydrochloride (Systemic); Setmelanotide Acetate; Sofpironium Bromide; Terbutaline Sulfate; Tisagenlecleucel; Ustekinumab; Vimseltinib Dihydrate; Vorasidenib; Vutrisiran Sodium.